Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2284853 | 1.00 | USP2 (0.40) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL2094040 | 1.00 | USP2 (0.40) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL1287846 | 0.98 | USP2 (0.39) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL3730156 | 0.98 | USP2 (0.37) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL30361807 | 0.92 | USP2 (0.37) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL28609548 | 0.86 | USP2 (0.31) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL29198910 | 0.83 | — | — | |
| SCHEMBL5497063 | 0.80 | USP2 (0.44) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL29973085 | 0.73 | CYP2C19 (0.42) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL3345554 | 0.72 | CYP2C19 (0.58) | USP2ALDH1A1LMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116528904-A | Radiopharmaceuticals and methods | 普罗博开发商业中心 | 2023-08-01 | — | — | CN | claimed |
| CN-116528904-A | Radiopharmaceuticals and methods | 普罗博开发商业中心 | 2023-08-01 | — | — | CN | disclosed |
| EP-4110407-A1 | RADIOLABELED FIBRONECTIN BASED SCAFFOLDS AND ANTIBODIES AND THERANOSTIC USES THEREOF | Bristol-Myers Squibb Company (US) | 2023-01-04 | — | — | EP | disclosed |
| WO-2015021305-A1 | CANCER CELL SPECIFIC IMAGING PROBES AND METHODS OF USE | THE RESEARCH FOUNDATION FOR THE STATE UNIVERISTY OF NEW YORK (US) | 2015-02-12 | — | — | WO | disclosed |